Common variable immunodeficiency and hemophagocytic features associated with a FAS gene mutation

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages

  Kuijpers, Taco W ^a   Baars, Paul A ^b   Aan De Kerk, Daan J ^a,b   Jansen, MacHiel H ^a,b   Dors, Natasja ^a   Van Lier, Rene A W ^b   Pals, Steven T ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BINDING PROTEIN; CD19 ANTIGEN; CD27 ANTIGEN; FAS ANTIGEN; FERRITIN; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; PERFORIN; PERFORIN 1; PNEUMOCOCCUS VACCINE; PREDNISONE; PROTEIN SH2; SH2 DOMAIN CONTAINING PROTEIN 1A; SYNTAXIN; SYNTAXIN 11 BINDING PROTEIN 2; T6 ANTIGEN; TETANUS TOXOID; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANEMIA; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; B LYMPHOCYTE ACTIVATION; CASE REPORT; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ERYTHROPHAGOCYTOSIS; EXON; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC ASSOCIATION; HEPATOSPLENOMEGALY; HUMAN; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOPENIA; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MALE; MEDICAL HISTORY; MEMORY CELL; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 79957830798     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.01.046     Document Type: Article

References (10)

1. Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 2005;11:370-6.
2. Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 1998;153:1541-50.
3. Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
4. Jackson CE, Fischer RE, Hsu AP, Anderson SM, Choi Y, Wang J, et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 1999;64:1002-14.
5. Rieux-Laucat F, Blachere S, Danielan S, De Villartay JP, Oleastro M, Solary E, et al. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999;94: 2575-82.
6. Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest 1999;103:355-63.
7. Freeman HR, Ramanan AV. Review of haemophagocytic lymphohistiocytosis. Arch Dis Child 2010 [Epub ahead of print].
8. Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rosen-Wolff A, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001;98:194-200.
9. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002;130:495-500.
10. Rensing-Ehl A, Warnatz K, Fuchs S, Schlesier M, Salzer U, Draeger R, et al. Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency. Clin Immunol 2010;137: 357-65.